Prophylactic Antibiotic Treatment During Vaginal Repair
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00162604|
Recruitment Status : Unknown
Verified February 2005 by Hvidovre University Hospital.
Recruitment status was: Recruiting
First Posted : September 13, 2005
Last Update Posted : September 11, 2006
Prolapse of the uterus, bladder and rectum is a common condition in multiparous and/or elderly women. The number of operations for vaginal repair is increasing in Denmark, but there is no consensus or evidence found about the efficiency of prophylactic antibiotics intraoperatively concerning postoperative infections.
The objective of this randomized, controlled trial is to investigate the significance of prophylactic antibiotic treatment in vaginal repair operations.
|Condition or disease||Intervention/treatment||Phase|
|Uterine Prolapse Cystocele Rectocele Enterocele||Drug: Cefuroxime||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||200 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Antibiotikaprofylakse Ved Vaginalplastik|
|Study Start Date :||May 2005|
- primary endpoint: no infections (urinary tract infections, pneumonia,wound infections, infected haematomas, etc.) within 30 days postoperatively
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00162604
|Contact: Marianne Ottesen, M.D||0045 36323632 ext firstname.lastname@example.org|
|Hvidovre University Hospital||Recruiting|
|Hvidovre, Denmark, 2650|
|Contact: Marianne Ottesen, M.D 0045 36323632 ext 3540 email@example.com|
|Sub-Investigator: Tina Olsen, M.D|
|Sub-Investigator: Abelone Elisabeth Sakse, M.D|
|Principal Investigator: Marianne Ottesen, M.D, PhD|
|Study Director:||Marianne Ottesen, M.D, Ph.D||Hvidovre University Hospital|